Ovarian steroid and cytokine modulation of human endometrial angiogenesis

Human Reproduction

Volumn 15, Issue , 2000, Pages 67-77

  Lebovic, Dan I ^a,b   Shifren, Jan L ^a,b   Ryan, Isabelle P ^a,b   Mueller, Michael D ^a,b   Korn, Abner P ^a,c   Darney, Philip D ^a,c,d   Taylor, Robert N ^a,b  

^a Gynecology and Reproductive Sciences ^*  (United States)

^b Center for Reproductive Sciences   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bleeding; Norplant; Progestins; Uterus; VEGF

Indexed keywords

CONTRACEPTIVE AGENT; CYTOKINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GAMMA INTERFERON; GESTAGEN; INTERLEUKIN 1BETA; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE RECEPTOR; STEROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOCRINE FUNCTION; ENDOMETRIUM; HORMONAL CONTRACEPTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; IN VITRO STUDY; MEDIATOR; MENSTRUAL CYCLE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; TISSUE GROWTH; UTERUS BLEEDING;

EID: 0033829305     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.suppl_3.67     Document Type: Article

References (76)

1. Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: Association with changes in ovarian and uterine Doppler blood flow
2. Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells
3. Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors
4. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use
5. Oestrogen receptor (ER)-a and ER-b isoforms in normal endometrial and endometriosis-derived stromal cells
6. Localization of T cells, interferon-gamma and HLA-DR in eutopic and ectopic human endometrium
7. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment
8. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen induced increases in uterine capillary permeability and growth
9. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users
10. The chicken vitellogenin II gene is flanked by a GATA factor-dependent estrogen response unit
11. Clinical assessment of treatment for prolonged bleeding in users of Norplant implants
12. Vascular endothelial growth factor (VEGF) in endometriosis
13. Capillaries and arterioles in normal endometrium
14. Long acting contraceptive implants. An analysis of menstral bleeding patterns
15. Proliferation kinetics of human endometrium during the normal menstrual cycle
16. Molecular and biological properties of the vascular endothelial growth factor family of proteins
17. Angiogenic factors
18. Effects of exogenous hormones on endometrial capillaries
19. Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells
20. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium
21. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells
22. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells
23. RANTES derived from normal endometrial and endometriosis stromal cells has altered bio- to immunoactivity
24. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels
25. Endometrial vascular features prior to and following exposure to levonorgestrel
26. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17beta-oestradiol
27. Human umbilical vein endothelial cells lack expression of the estrogen receptor
28. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 microgram norethisterone (NET) minipill
29. Angiogenesis in the postovulatory primate endometrium: The coiled anteriolar system
30. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
31. A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor
32. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
33. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1b
34. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid
35. The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium
36. Menstruation in intraocular endometrial transplants in the rhesus monkey
37. The estrogen-responsive elements as an inducible enhancer: DNA sequence requirements and conversion to a glucorticoid-responsive element
38. Endometrial morphology in women exposed to uterine systems releasing progesterone
39. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation
40. Dating the endometrial biopsy
41. Free levonorgestrel index (FLI) is a better parameter than plasma level of levonorgestrel for predicting risk of pregnancy during use of subdermal contraceptive implants releasing levonorgestrel
42. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
43. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans
44. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle
45. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells: Implications for the neovascularization of normal and neoplastic endometrium
46. Endothelial cell migratory signal produced by human endometrium during the mentrual cycle
47. Endometrial microvascular density during the normal menstrual cycle and following exposure to long term levonorgestrel
48. Response of tumour cells to hypoxia: Role of p53 and NFkB
49. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro
50. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells
51. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-montly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction
52. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception
53. Differential effects of estradiol, arachidonic acid, and A23187 on protiglandin F2 alpha output by epithelial and stromal cells of human endometrium
54. Regulation of vacular endothelial growth factor expression in human endometrium by steroids and hypoxia: In vitro and in vivo studies
55. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
56. The significance of bleeding patterns in Norplant implant users
57. Interleukin-1 type I receptor messenger ribonucleic acid expression in human endometrium throughout the menstrual cycle
58. Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: Morphometric assessment of the uterus and oviduct
59. Angiogenesis, vascular endothelial growth factor and the endometrium
60. In vitro decidualization of human endometrial stromal cells
61. Cytokine expression in human endometrium throughout the menstrual cycle
62. Antiproliferative effect of interferon-gamma in human endometrial epithelial cells in vitro: Potential local growth modulatory role in endometrium
63. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium
64. Angiogenesis and macrophage activation in endometriosis
65. Ovarian steroids and angiogenesis
66. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing
67. Vascular endothelial growth factor expression in cycling human endometrium
68. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis
69. Progesterone regulates proliferation of endothelial cells
70. Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters
71. Fos-related Antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity
72. Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring
73. Oestrogen treatment for increased bleeding in Norplant users: Preliminary results
74. Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway
75. IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils